Luigi De Petris

Luigi De Petris

UNVERIFIED PROFILE

Are you Luigi De Petris?   Register this Author

Register author
Luigi De Petris

Luigi De Petris

Publications by authors named "Luigi De Petris"

Are you Luigi De Petris?   Register this Author

39Publications

829Reads

41Profile Views

Genes and variants in hematopoiesis-related pathways are associated with gemcitabine/carboplatin-induced thrombocytopenia.

Pharmacogenomics J 2019 Oct 15. Epub 2019 Oct 15.

Clinical Pharmacology, Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41397-019-0099-8DOI Listing
October 2019

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.

Lung Cancer 2018 06 30;120:75-81. Epub 2018 Mar 30.

Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.03.026DOI Listing
June 2018

Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.

Acta Oncol 2018 Feb 6;57(2):231-238. Epub 2017 Oct 6.

a Department of Oncology , Karolinska University Hospital , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1386799DOI Listing
February 2018

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 12 31;34(34):4079-4085. Epub 2016 Oct 31.

Shirish M. Gadgeel, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Alice T. Shaw, Massachusetts General Hospital; Leena Gandhi, Dana-Farber Cancer Institute, Boston, MA; Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Mark A. Socinski, University of Pittsburgh, Pittsburgh, PA; D. Ross Camidge, University of Colorado Cancer Center, Denver, CO; Alberto Chiappori, Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Sai-Hong Ignatius Ou, University of California at Irvine, Orange, CA; Luigi De Petris, Karolinska Institutet, Stockholm, Sweden; Dong-Wan Kim, Seoul National University Hospital, Seoul; Ji-Youn Han, Lung Cancer Centre, National Cancer Centre, Goyang, South Korea; Denis L. Moro-Sibilot, Service de Pneumologie; Michael Duruisseaux, Centre Hospitalier Universitaire de Grenoble, Grenoble; Eric Dansin, Centre Oscar Lambret, Lille, France; Lucio Crino, Santa Maria della Misericordia Hospital, Perugia; Tommaso De Pas, European Institute of Oncology, Milan, Italy; Antje Tessmer, Evangelische Lungenklinik Berlin, Berlin, Germany; James Chih-Hsin Yang, Graduate Institute of Oncology and Cancer Research Centre, National Taiwan University, Taipei, Taiwan; and Walter Bordogna, Sophie Golding, and Ali Zeaiter, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.4639DOI Listing
December 2016

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors:
Christian Dittrich Michael Kosty Svetlana Jezdic Doug Pyle Rossana Berardi Jonas Bergh Nagi El-Saghir Jean-Pierre Lotz Pia Österlund Nicholas Pavlidis Gunta Purkalne Ahmad Awada Susana Banerjee Smita Bhatia Jan Bogaerts Jan Buckner Fatima Cardoso Paolo Casali Edward Chu Julia Lee Close Bertrand Coiffier Roisin Connolly Sarah Coupland Luigi De Petris Maria De Santis Elisabeth G E de Vries Don S Dizon Jennifer Duff Linda R Duska Alexandru Eniu Marc Ernstoff Enriqueta Felip Martin F Fey Jill Gilbert Nicolas Girard Andor W J M Glaudemans Priya K Gopalan Axel Grothey Stephen M Hahn Diana Hanna Christian Herold Jørn Herrstedt Krisztian Homicsko Dennie V Jones Lorenz Jost Ulrich Keilholz Saad Khan Alexander Kiss Claus-Henning Köhne Rainer Kunstfeld Heinz-Josef Lenz Stuart Lichtman Lisa Licitra Thomas Lion Saskia Litière Lifang Liu Patrick J Loehrer Merry Jennifer Markham Ben Markman Marius Mayerhoefer Johannes G Meran Olivier Michielin Elizabeth Charlotte Moser Giannis Mountzios Timothy Moynihan Torsten Nielsen Yuichiro Ohe Kjell Öberg Antonio Palumbo Fedro Alessandro Peccatori Michael Pfeilstöcker Chandrajit Raut Scot C Remick Mark Robson Piotr Rutkowski Roberto Salgado Lidia Schapira Eva Schernhammer Martin Schlumberger Hans-Joachim Schmoll Lowell Schnipper Cristiana Sessa Charles L Shapiro Julie Steele Cora N Sternberg Friedrich Stiefel Florian Strasser Roger Stupp Richard Sullivan Josep Tabernero Luzia Travado Marcel Verheij Emile Voest Everett Vokes Jamie Von Roenn Jeffrey S Weber Hans Wildiers Yosef Yarden

ESMO Open 2016 29;1(5):e000097. Epub 2016 Sep 29.

Department of General Medical Oncology , University Hospitals Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070299PMC
September 2016

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

J Clin Oncol 2016 Mar 23;34(7):661-8. Epub 2015 Nov 23.

Sai-Hong Ignatius Ou, University of California Irvine School of Medicine, Orange, CA; Jin Seok Ahn, Sungkyunkwan University School of Medicine; Luigi De Petris, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden; Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; James Chih-Hsin Yang, National Taiwan University, Taipei, Taiwan; Brett Hughes, The Prince Charles Hospital, Chermside, and University of Queensland, Queensland, Australia; Hervé Lena, Centre Hospitalier Universitaire de Rennes, Rennes; Denis Moro-Sibilot, Centre Hospitalier Universitaire de Grenoble, Institut National de la Santé et de la Recherche Médicale U823, Grenoble, France; Alessandra Bearz, National Cancer Institute, Aviano, Italy; Santiago Viteri Ramirez, Quiron-Dexeus University Hospital, Barcelona, Spain; Tarek Mekhail, Florida Hospital Cancer Institute, Orlando, FL; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; and Walter Bordogna, Bogdana Balas, Peter N. Morcos, Annabelle Monnet, and Ali Zeaiter, F. Hoffmann-La Roche, Basel, Switzerland; Dong-Wan Kim, Seoul National University Hospital, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/jco.2016.34.4_suppl.661DOI Listing
March 2016

miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.

Genes Chromosomes Cancer 2013 Oct 9;52(10):895-911. Epub 2013 Aug 9.

Department of Oncology-Pathology, Karolinska Biomics Center, Karolinska Institutet, SE-171 76, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22085DOI Listing
October 2013

Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism.

J Proteome Res 2013 Sep 13;12(9):3934-43. Epub 2013 Aug 13.

Cancer Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr4002096DOI Listing
September 2013

Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.

Acta Oncol 2013 Aug 7;52(6):1189-94. Epub 2012 Dec 7.

Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital Solna, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2012.742960DOI Listing
August 2013

Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer.

Eur J Cancer 2011 Jan 6;47(1):131-7. Epub 2010 Sep 6.

Clinical Proteomics, Karolinska Biomics Center, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.08.006DOI Listing
January 2011

Lung cancer proteomics, clinical and technological considerations.

J Proteomics 2010 Sep 1;73(10):1851-63. Epub 2010 Jun 1.

Karolinska Biomics Center, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2010.05.015DOI Listing
September 2010

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

Lung Cancer 2009 Mar 11;63(3):410-7. Epub 2008 Jul 11.

Karolinska Biomics Center, Karolinska Intitutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.06.003DOI Listing
March 2009

Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.

Crit Rev Oncol Hematol 2007 Jul 26;63(1):53-64. Epub 2007 Mar 26.

Division of Medical Oncology, S.G. Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2007.01.008DOI Listing
July 2007

Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer.

Med Oncol 2005 ;22(4):375-81

Department of Oncology and Pathology, Radiumhemmet, Karolinska University Hospital, 17176, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MO:22:4:375DOI Listing
February 2006

Second-line treatment options in non-small cell lung cancer: a comparison of cytotoxic agents and targeted therapies.

Semin Oncol 2006 Feb;33(1 Suppl 1):S17-24

5th Pneumo-oncology Unit, Department of Oncology, S. Camillo-Forlanini Hospitals, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2005.12.004DOI Listing
February 2006

Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study.

Anticancer Res 2005 Nov-Dec;25(6C):4713-7

5th Pneumo-Oncology Unit, Department of Oncology, S. Camillo-Forlanini Hospitals, V. Portuense 332, 00149 Rome, Italy.

View Article

Download full-text PDF

Source
January 2006

The role of p53 in treatment responses of lung cancer.

Biochem Biophys Res Commun 2005 Jun;331(3):868-80

Unit of Medical Radiobiology, Department of Oncology/Pathology, Cancer Center Karolinska R8:00, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2005.03.192DOI Listing
June 2005

Pemetrexed in second-line treatment of non-small-cell lung cancer.

Oncology (Williston Park) 2004 Nov;18(13 Suppl 8):38-42

Pulmonary-Oncology Unit, Department of Lung Diseases, Forlanini Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
November 2004

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.

Med Oncol 2004 ;21(1):49-52

Department of Oncology, Radiumhemmet, Karolinska Hospital, 17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MO:21:1:49DOI Listing
July 2004

[The role of adjuvant chemotherapy in the treatment of early stage NSCLC after radical surgery].

Suppl Tumori 2004 Jul-Aug;3(4):S50-1

Ospedale Forlanini, Roma.

View Article

Download full-text PDF

Source
July 2004

Neoadjuvant strategies for non-small cell lung cancer.

Suppl Tumori 2004 Mar-Apr;3(2):S49-51

5th Pulmonary Oncological Unit, Carlo Forlanini Hospital, Rome.

View Article

Download full-text PDF

Source
April 2004